Pictet Asset Management Holding SA »

Castle Biosciences shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2025-12-31 $230k 5.9k 38.90

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corp Call Call Option (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon Call Call Option (AMZN)
Broadcom (AVGO)
Ubs Group SHS (UBS)
Thermo Fisher Scientific (TMO)
Meta Platforms Cl A (META)
Kla Corp Com New (KLAC)
salesforce (CRM)
Ecolab (ECL)
Nxp Semiconductors N V (NXPI)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)

View all positions for Pictet Asset Management Holding SA

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences